A hallmark of Staphylococcus aureus disease in humans is persistent infections without development of protective immune responses. Infected patients generate V H 3 plasmablast expansions and increased V H 3 idiotype Ig; however, the mechanisms for staphylococcal modification of immune responses are not known. We report here that S. aureus-infected mice generate V H 3 antibody expansions via a mechanism requiring MHC-restricted antigen presentation to CD4 + T cells and staphylococcal protein A (SpA), a cell wall-anchored surface molecule that binds Fcγ and V H 3 variant heavy chains of Ig. V H 3 expansion occurred with peptidoglycan-linked SpA from the bacterial envelope but not with recombinant SpA, and optimally required five tandem repeats of its Ig-binding domains. Signaling via receptor-interacting serine/threonine protein kinase 2 (RIPK2) was essential for implementing peptidoglycan-linked SpA superantigen activity. V H 3 clan IgG from S. aureus-infected or SpA-treated animals was not pathogen-specific, suggesting that SpA cross-linking of V H 3 idiotype B-cell receptors and activation via attached peptidoglycan are the determinants of staphylococcal escape from adaptive immune responses. 
A hallmark of Staphylococcus aureus disease in humans is persistent infections without development of protective immune responses. Infected patients generate V H 3 plasmablast expansions and increased V H 3 idiotype Ig; however, the mechanisms for staphylococcal modification of immune responses are not known. We report here that S. aureus-infected mice generate V H 3 antibody expansions via a mechanism requiring MHC-restricted antigen presentation to CD4 + T cells and staphylococcal protein A (SpA), a cell wall-anchored surface molecule that binds Fcγ and V H 3 variant heavy chains of Ig. V H 3 expansion occurred with peptidoglycan-linked SpA from the bacterial envelope but not with recombinant SpA, and optimally required five tandem repeats of its Ig-binding domains. Signaling via receptor-interacting serine/threonine protein kinase 2 (RIPK2) was essential for implementing peptidoglycan-linked SpA superantigen activity. V H 3 clan IgG from S. aureus-infected or SpA-treated animals was not pathogen-specific, suggesting that SpA cross-linking of V H 3 idiotype B-cell receptors and activation via attached peptidoglycan are the determinants of staphylococcal escape from adaptive immune responses. (1) . The nares, skin, and gastrointestinal tract of approximately one-third of the human population are stably colonized, whereas another third is intermittently colonized (2) . Colonization increases the risk of S. aureus infection, specifically for skin and soft tissue infection, invasive disease, as well as bacteremia (3, 4) . S. aureus infection leads to the formation of abscess lesions supporting pathogen replication and dissemination (5) . Even with antibiotic and surgical therapy (drainage of abscess lesions), S. aureus persists and causes recurrent disease, manifesting as relapse infections by strains responsible for the index case (6, 7) . S. aureus persistence, recurrent disease, and the overall outcome of infections (morbidity and mortality) are impacted by the development of antibioticresistant strains, designated MRSA (methicillin-resistant S. aureus) (8) . The emergence of MRSA strains has led to dramatic increases in the mortality of S. aureus infections, highlighting the need for development of new therapeutic and preventive strategies (9, 10) .
S. aureus-infected individuals display expansions of blood V H 3 clonal plasmablasts and V H 3 clonal antibodies (11) . Staphylococcal protein A (SpA), a cell wall-anchored molecule that is also released from the bacterial surface, associates with the variant heavy chains of V H 3 clonal IgG and IgM (B-cell receptors) (12, 13) . Earlier work reported that SpA on bacterial surfaces but also SpA purified from S. aureus cell walls stimulate the proliferation of human peripheral blood B lymphocytes (14) . In contrast, injection of recombinant SpA, purified from Escherichia coli, into mice induced trafficking and apoptosis of marginal zone B cells and innate-like B1 cells (15) (16) (17) . Persistent depletion of functional B-cell repertoires suggested that animals treated with recombinant SpA may be more susceptible to infections with blood-borne pathogens (18) . In agreement with these observations, injection of recombinant SpA into mice with systemic lupus erythematosus (SLE) depletes B1 and marginal zone B cells to alleviate antibodyinduced nephritis and renal failure associated with SLE (19) .
We sought to address the apparent paradox between V H 3 clonal B-cell expansion during S. aureus infection in humans and the collapse of V H 3 clonal B cells in mice treated with recombinant SpA. Earlier work demonstrated that S. aureus sortase A cleaves SpA precursors and covalently links the C-terminal end of polypeptides to peptidoglycan cross-bridges in the cell-wall envelope (20, 21) . LytM hydrolase cuts the staphylococcal cell wall to release peptidoglycan-linked SpA into the extracellular medium (22) . We show here that peptidoglycan-linked SpA, but not recombinant SpA, induces V H 3 clonal antibody expansions in mice.
Results and Discussion S. aureus Infection of Mice Triggers V H 3 Antibody Expansions. Intravenous inoculation of C57BL/6 mice with 1 × 10 7 colonyforming units (CFUs) of S. aureus Newman causes bacteremia and persistent abscess formation in all tissues of infected animals (23) . To determine whether infected mice expand V H 3 clonal antibodies, animals were bled 5, 12, 19, and 26 d following S. aureus inoculation and serum was analyzed for V H 3 clan IgM and IgG by ELISA with SpA KK , a protein A variant that binds V H 3 variant heavy chains but not Ig Fcγ (24) . Compared with mock-infected mice, the abundance of V H 3 clonal IgM was increased by 48-fold on day 5 following inoculation (wild-type S. aureus vs. mock; P < Significance Staphylococcus aureus infection of humans is associated with immunoglobulin expansions but not with the development of immunity against recurrent disease. The mechanism whereby staphylococci manipulate the host immune system to block adaptive immunity is not known. We show here that S. aureus infection of mice is also associated with immunoglobulin expansions and that staphylococcal protein A (SpA), a molecule that cross-links B-cell receptors, is both necessary and sufficient for this immune evasion mechanism. Further, SpA requires covalent linkage to bacterial peptidoglycan and CD4 T-cell help to manipulate the immunoglobulin responses of infected hosts. Our results provide insights into microbial signaling mechanisms for B-cell activation and antibody development.
0.0001) and thereafter declined as measured on days 12 and 19 (Fig. 1A) . Further, S. aureus infection caused a 247-fold increase in the abundance of V H 3 clonal IgG on day 12 (P < 0.0001), which remained elevated for the remainder of the experiment (days 12, 19, and 26; Fig. 1C ). As a control, serum IgM and IgG from S. aureus or mock-infected animals did not bind to SpA KKAA , a protein A variant that binds neither Ig V H 3 variant heavy chains nor Fcγ ( Fig. 1 B and D) (25) . Antibody expansions were not observed when mice were injected with formalin-killed wild-type S. aureus, indicating that live bacteria are required for this phenotype (Fig. S1) . Thus, similar to V H 3 clonal plasmablast and Ig expansions in humans with staphylococcal disease, S. aureusinfected mice also expand their V H 3 clonal IgM and IgG antibodies and fail to produce Ig that recognizes protein A as antigen.
Antibody Expansion Relies on Protein A Binding to V H 3 Heavy Chains.
The structural gene for protein A (spa) of S. aureus Newman encodes a precursor with an N-terminal cleavable signal peptide, five Ig-binding domains (IgBDs), the cell wall-spanning region (region X), and the C-terminal LPXTG sorting signal for cell-wall attachment of the mature product (26) (27) (28) (29) . Each IgBD is endowed with two conserved glutaminyl (Q 9,10 ) and aspartyl residues (D 36, 37 ) that are critical for Fcγ and Fab binding, respectively (25) . A variant, spa KKAA , with substitutions of these glutaminyl (Q 9 K, Q 10 K) and aspartyl (D 36 A, D 37 A) residues in each of the five IgBDs, is unable to bind the V H 3 variant chains or Fcγ of immunoglobulins (24) . In contrast, spa variants carrying only glutaminyl (Q 9 K, Q 10 K in SpA KK ) or aspartyl substitutions (D 36 A, D 37 A in SpA AA ) in their five IgBDs retain the ability to bind either V H 3 variant chains or Fcγ, respectively (24) . When used in the i.v. challenge model, the spa KKAA variant of S. aureus Newman did not cause expansions of V H 3 clonal IgM and IgG ( Fig. 1 A and  C) . A similar result was obtained in mice infected with the spa AA variant, whereas S. aureus expressing spa KK promoted V H 3 clonal IgM and IgG expansions resembling those of animals challenged with wild-type staphylococci ( Fig. 1 A and C) . Similar to wild-type infected mice, serum IgM and IgG from spa KK -, spa AA -, and spa KKAA -infected animals did not bind to SpA KKAA ( Fig. 1 B and  D) . These data indicate that protein A, specifically the D 36 , 37 residues in each of the five IgBDs responsible for heavy-chain binding to B-cell receptors, is required for the expansion of V H 3 clonal antibodies during S. aureus infection. (28), whose coding sequence is located upstream of the highly variable region X in the spa gene, otherwise used for genotyping S. aureus (27, 32, 33) (Fig.  2A) . We investigated whether infection with MRSA clinical isolates would trigger V H 3 + antibody expansions in mice. Immunoblot analysis revealed that three representative MRSA isolates, strains USA300 LAC, MW2, and N315, expressed similar amounts of SpA in the bacterial envelope (Fig. 2B) . However, USA300 LAC and MW2 released increased amounts of SpA into the extracellular medium compared with N315 ( quantified (Fig. 2 C and D) . Mice infected with methicillin-sensitive S. aureus (MSSA) or MRSA isolates generated a 5-to 12-fold increase in SpA KK + (V H 3) IgM antibody on day 5 post infection ( Fig. 2C) . As SpA KK + (V H 3 + ) IgM decreased, V H 3 IgG antibody levels increased sharply in MRSA USA300-or MW2-infected animals, leading to >200-fold expansion of Ig (Fig. 2D) . In contrast, mice infected with MRSA isolate N315 displayed a moderate 51-fold expansion of V H 3 + IgG on day 12, which subsequently waned (Fig. 2D) . The spa gene of MRSA N315 encodes only four IgBDs, suggesting that the amplitude of V H 3 antibody expansions may be a function of protein A IgBD repeats ( Fig. 2A) .
IgBD Repeat Variation Affects Staphylococcal Binding to Ig Heavy
Chains. Analysis of 3,905 community-and 2,205 hospital-associated S. aureus isolates from Oxfordshire, United Kingdom, revealed that all strains carried intact spa ORFs (34) . Rearrangements in the spa gene were observed for IgBD coding sequence in 1.8% of community and 0.6% of hospital isolates (34) . Most of these gene rearrangements are in-frame deletions of either the D, B, or C domain coding sequence, resulting in protein A variants with only four IgBDs, similar to that observed for MRSA strain N315 (34) . Gene rearrangements with deletions of coding sequence for two, three, or four IgBDs are much more rare (1/6,110) (34) . These findings suggest that the IgBD tandem repeats in the spa gene are subject to variation via homologous recombination, as has been observed for other microbial virulence factors with tandem repeat sequences (35, 36) . Because spa genes with five IgBDs are present in >98% of isolates, it appears that the number of SpA Ig domains displayed on the surface of S. aureus is subject to purifying selection.
We wondered whether variations in the number of IgBD repeats of spa genes impact the B-cell superantigen activity of S. aureus isolates. To analyze this, we created five variants of S. aureus Newman-expressing spa genes with one (spa E ), two (spa ED ), three (spa EDA ), four (spa EDAB ), or six (spa EDABCD ) IgBDs and compared their biological attributes with the wild-type parent (spa EDABC ) and the Δspa deletion mutant (Fig. 3A) . Flow cytometry analysis of bacteria stained with α-SpA KKAA antibody revealed that all spa variants expressed and anchored protein A on the staphylococcal surface (Fig. S2A) . The capacity to bind human IgG varied among mutants. Whereas the Δspa mutant retained only small amounts of IgG, increasing amounts of Ig were captured on the surface of staphylococci expressing protein A with one, two, three, four, five, or six IgBDs (Fig. S2B) . A similar result was obtained following incubation with fluorophore-conjugated human IgG-Fcγ fragments (Fig. S2C) . In contrast, S. aureus variants expressing protein A with one (spa E ), two (spa ED ), or three IgBDs (spa EDA ) did not retain significant amounts of fluorophoreconjugated human IgG F(ab) 2 on the bacterial surface (Fig. S2D) . On the other hand, strains with four (spa EDAB ), five (spa EDABC ), or six (spa EDABCD ) IgBDs bound increasing amounts of IgG heavy chains (Fig. S2D ). Mice were infected with the various spa mutant strains, and blood was sampled on days 5 and 14 post infection and analyzed for V H 3 + IgM and IgG (Fig. 3 B-E) . Compared with the Δspa mutant, strains expressing more than three IgBDs (spa EDAB , spa EDABC , and spa EDABCD ) caused a significant increase in V H 3 + IgM on days 5 and 14, whereas the spa E , spa ED , and spa EDA variants did not (Fig. 3 B and D) . Only the spa EDAB , spa EDABC , and spa EDABCD mutant strains increased V H 3 clonal IgG during infection (Fig. 3 C and E) . Although SpA EDABCD displayed the highest capacity for binding to human F(ab) 2 (Fig. S2D ), mice infected with the spa EDABCD mutant showed diminished expansion of V H 3 clonal IgM and IgG (spa EDABC ; Fig. 3 B-E) . Thus, S. aureus strains expressing protein A with five IgBD repeats display greater B-cell superantigen activity than isolates with fewer or more repeats, a mechanism that may support purifying selection during infection. Mature, cell wall-anchored protein A is released from the staphylococcal surface during bacterial growth, and this molecule may modify the adaptive immune system of infected hosts by cross-linking B-cell receptors (22) . Unlike recombinant protein A (rSpA), purified without the C-terminal sorting signal from E. coli, native SpA (nSpA) released from the S. aureus cell wall is modified with murein tetrapeptide-tetraglycyl [L-Ala-D-iGln-(SpA-Gly 5 -)L-Lys-D-Ala-Gly 4 ] linked to its C-terminal threonyl residue (22) (Fig. 4A) . We asked whether i.p. administration of purified rSpA and nSpA promotes V H 3 antibody expansions. Cohorts of naïve mice were treated with 0.1-100 μg of rSpA on days 0, 5, 12, and 19 and V H 3 + IgM and IgG antibodies were quantified (Fig. 4 B and C) . As expected from earlier work studying the impact of rSpA on V H 3 + B cells in mice (15) , repeated injection of mice with rSpA did not expand V H 3 clan IgM and IgG antibody levels (Fig. 4 B and C) . In contrast, mice treated with 10 μg of nSpA mounted a 4.3 (±1.4)-fold increase in V H 3 + IgM and a 41.1 (±23.8)-fold increase in V H 3 + IgG antibodies on day 26 post injection ( Fig. 4 D and E) . These data (Fig. 4 F and G) . However, treatment of Δspa-infected mice with nSpA caused enhanced SpA KK
IgM and IgG antibody production as early as day 12 post infection (Fig. 4 F and G) Antigen recognized by B-cell receptors is endocytosed, processed, and loaded onto MHC class II (H-2) compartments for presentation to CD4 + T cells (37) . The quality and quantity of antibody responses to a given antigen are under genetic control of the H-2 locus (38). SpA-activated B cells induce proliferation of human T cells in an MHC class II-dependent manner (39) . To determine whether a specific H-2 type favors V H 3 antibody expansion, multiple inbred mouse strains with well-defined MHC haplotypes were treated with nSpA, and blood samples were analyzed for V H 3 + IgM and IgG responses ( Fig. 5 A and B) . H-2 a (A/J) and H-2 q (FVB/N) animals developed fulminant antibody expansions. H-2 d (BALB/c and DBA/2) animals generated variable responses, whereas H-2 b and H-2 k (C3H/HeJ, C57BL/6, and CBA) mice responded in a moderate manner (Fig. 5 A and B) . The abundance of preexisting V H 3 clonal antibodies in the blood of various mouse strains was not correlated with the magnitude of antibody expansions following nSpA treatment (Fig. 5C ).
Nucleotide oligomerization domain 1 (NOD1) and 2 (NOD2) are intracellular receptors that activate nuclear factor κB (NF-κB)-mediated inflammatory signaling in response to bacterial peptidoglycan (40) . Receptor-interacting serine/threonine protein kinase 2 (RIPK2) acts as an adaptor, downstream of NOD1 and NOD2, and is essential for peptidoglycan-mediated NF-κB activation (41) . Toll-like receptor 2 (TLR2) recognizes peptidoglycan and lipoteichoic acid on the cell surface (42) . The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) is activated by a variety of pathogen-associated molecular patterns (PAMPs) to up-regulate caspase 1-mediated release of interleukin 1β (43) . To investigate the role of peptidoglycan-linked protein A in promoting B-cell superantigen activity, wild-type C57BL/6 and TLR2, NLRP3, or RIPK2 knockout mice were treated with nSpA ( Fig. 4  B and C) . Upon nSpA treatment, TLR2 and NLRP3 knockout mice responded with V H 3 + antibody expansions similar to wildtype mice (Fig. 5E ). In contrast, RIPK2 knockout mice failed to expand V H 3 clonal IgM and IgG, suggesting that peptidoglycanlinked protein A stimulates the immune system via the NOD1 and NOD2 signaling pathways and their RIPK2 adaptor.
Requirement of CD4
+ T Cells for V H 3 Antibody Expansions. B-cell antibody class switching is modulated by CD4 + T helper cells (44) . Human plasmablasts isolated from patients with S. aureus infection produced affinity-matured, class-switched V H 3 clonal antibodies (11) . V H 3 + B cells activated by S. aureus infection of mice undergo class switching from IgM to IgG between 5 and 12 d post infection, leading to the corresponding changes in V H 3 clonal Ig. We therefore wondered whether CD4
+ T helper cells are also required for V H 3 clonal Ig expansion. Mice were treated with multiple doses of rat monoclonal antibodies targeting CD4 or CD8α or mock-treated with PBS. Depletion of CD4 or CD8α T cells was verified by flow cytometry analysis of splenocytes (Fig. S3 A-C). Following i.v. infection with wild-type S. aureus, mice were monitored for morbidity and mortality. As expected from earlier work demonstrating the contribution of T cells toward innate immunity against S. aureus (45, 46), mice depleted of CD4-or CD8α-positive T cells were more susceptible to staphylococcal challenge and displayed increased mortality (Fig. S3D ). Blood samples of infected mice were collected on days 5 and 12 post challenge and serum IgM and IgG levels were analyzed (Fig. S3 E  and F) . Animals treated with PBS or α-CD8α displayed similar expansions of V H 3 clonal IgM and IgG (Fig. S3 E and F) . In contrast, CD4 T cell-depleted mice were unable to expand V H 3 clonal Ig during staphylococcal infection (Fig. S3 E and F) . These data suggest that CD4
+ T helper cells contribute to V H 3 clonal Ig expansions and class switching from IgM to IgG. To assess whether B cells in S. aureus-infected mice generate adaptive immune responses specific to staphylococcal antigens, cohorts of mice were infected with S. aureus Newman or its spa KKAA variant for 14 d. Hyperimmune serum from animals in the same cohort was pooled and subjected to affinity chromatography ( Fig. S4 A and B) . ELISA analysis revealed that affinity-purified V H 3 + IgG from wild-type S. aureus-infected mice was predominantly of the IgG 2a and IgG 2b isotypes, whereas V H 3 + IgG from spa KKAA variant-infected mice harbored similar amounts of all isotypes (Fig. S4C) . Of 12 staphylococcal antigens (Coa, ClfA, ClfB, EsxA, EsxB, Hla, IsdA, IsdB, LukD, SdrC, SdrD, and SdrE) examined, only 4 antigens-Hla, IsdA, IsdB, and LukD-were recognized by SpA KK + or SpA KK − IgG generated during infection with wild-type S. aureus (Fig. S5) . The total amount of SpA KK + IgG from mice infected with the spa KKAA variant recognizing IsdA, IsdB, Hla, and LukD was increased (Fig. S5) . Conversely, there was a significant reduction in SpA KK − IgG in mice infected with the spa KKAA variant recognizing these four antigens. These data suggest that S. aureus-infected mice cannot generate pathogen-specific adaptive immune responses via their V H 3 antibody repertoire due to the B-cell superantigen attributes of protein A.
Studies in humans with S. aureus infection revealed expansions of V H 3 clonal plasmablasts and Ig (11) . The expanded repertoire of V H 3 + antibodies bind via variant heavy chains to SpA or SpA KK ; however, all plasmablast-derived monoclonal antibodies examined failed to recognize pathogen-specific antigens (11) . We demonstrate here that V H 3 clonal Ig expansion occurs in S. aureus-infected mice via a mechanism requiring the Fab binding sites of SpA IgBDs, namely aspartyl residues 36 and 37. Moreover, V H 3 clonal Ig expansion is dependent on peptidoglycan-linked SpA, which is released from the bacterial cell-wall envelope by staphylococcal murein hydrolases (22 
Materials and Methods
Flow Cytometry. For T-cell depletion, 6-wk-old C57BL/6 mice (n = 3) received CD4-or CD8α-specific monoclonal antibodies. After 5 d, animals were killed and their spleens were removed and homogenized. Red blood cells were lysed in ACK buffer (0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA). White blood cells were washed and suspended in PBS and stained with allophycocyanin-conjugated α-CD3e (145-2C11; eBioscience) and R-phycoerythrin-conjugated α-CD4 (RM4-5; Life Technologies), α-CD8α (5H10; Life Technologies), or CD19 (1D3; eBioscience) monoclonal antibodies. Cells were washed in 1% FBS/PBS and fixed with 4% (vol/vol) formalin and analyzed on a FACSCanto (University of Chicago flow cytometry core facility). Data were analyzed by FlowJo software.
In Vivo Mouse Experiments. Overnight cultures of S. aureus strains were diluted 1:100 into fresh tryptic soy broth and grown for 2 h at 37°C. Staphylococci were sedimented, washed, and suspended in PBS to the desired bacterial concentration. Inocula were quantified by spreading sample aliquots on TSA (tryptic soy agar) and enumerating CFUs. BALB/c or C57BL/6 mice (Charles River Laboratories and Jackson Laboratory) were anesthetized via i.p. injection with 65 mg·mL −1 ketamine and 6 mg·mL −1 xylazine per kg of body weight. Mice were infected by injection with 1 × 10 7 CFUs of S. aureus Newman and its variants or 5 × 10 6 CFUs of S. aureus USA300, MW2, or N315 into the periorbital venous sinus of the right eye. On days 5, 12, 14, 19, and 26 following infection, mice were anesthetized and bled either by heparin-coated capillary tubes from the periorbital venous sinus of the left eye or by cardiac puncture. For B-cell superantigen activity of rSpa or nSpA, A/J, BALB/c, C3H/HeJ, C57BL/6, CBA, DBA/2, or FVB/N mice (Jackson Laboratory) were treated by i.p. injection with 0.1-100 μg rSpA or nSpA on days 0, 5, 12, and 19. CD4-or CD8-specific T-cell depletion was achieved by i.p. injections of 0.5 mg purified rat monoclonal antibodies specific to mouse CD4 (GK1.5; Bio X Cell) or CD8α (53-6.72; Bio X Cell). Acute T-cell depletion was achieved by injecting monoclonal antibodies for 3 consecutive days, followed by repeated injections of the monoclonal antibodies at 3-d intervals.
All mouse experiments were performed at least twice, and were conducted in accordance with the institutional guidelines following experimental protocol review and approval by the Institutional Biosafety Committee (IBC) and the Institutional Animal Care and Use Committee (IACUC) at the University of Chicago.
Protein A Expression in S. aureus. Overnight cultures of staphylococci were diluted 1:100 and grown at 37°C with shaking to A 600 2. Fractionation of staphylococci into medium and cell-wall compartments followed a previously established procedure (29) . Briefly, bacteria were centrifuged (8,000 × g for 10 minutes) and the extracellular medium in the supernatant was precipitated with 5% TCA. The pellet was suspended in TSM [50 mM Tris (pH 7.5), 500 mM sucrose, 10 mM MgCl 2 with 100 μg·mL −1 lysostaphin] and incubated at 37°C to solubilize the cell-wall envelope with lysostaphin. The resulting protoplasts were sedimented by centrifugation (8,000 × g for 10 minutes), and the supernatant was precipitated with TCA (cell-wall fraction). TCA-precipitated proteins were washed in acetone, dried, solubilized in sample buffer, and separated on SDS/ PAGE. Proteins were electrotransferred to PVDF membrane and analyzed by immunoblotting using HRP-conjugated human IgM.
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